ZBH
Zimmer Biomet Holdings, Inc.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Zimmer Biomet (ZBH) Stock: Buy, Sell, or Hold?
$107.32
-1.01 (-0.93%)
▼
5d:
+10.57%
30d:
+16.44%
90d:
+9.63%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect ZBH Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
30/100
Position
EXTENDED
30-Day Fair Range
$90.31 – $102.48
Position: EXTENDED
Forward P/E & Valuation
12.0x
STRETCHED
vs 10.3x historical avg
Wall Street Target
$116.24
+8.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$94.38 / $112.55
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ZBH shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ZBH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$115.22
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$71.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZBH is currently trading at $107.32, which is considered extended relative to its 30-day fair value range of $90.31 to $102.48. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.0) compared to its historical average (10.3). At these levels, the market is pricing in 5.1% annual earnings growth.
Technical Outlook: Technically, ZBH is in a uptrend. Immediate support is located at $94.38, while resistance sits at $112.55.
Market Sentiment: ZBH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZBH is in a uptrend. Immediate support is located at $94.38, while resistance sits at $112.55.
Market Sentiment: ZBH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$90.31 -
$102.48
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$90.31 -
$102.48
Current vs Trading Range
EXTENDED
Support Level
$94.38
Resistance Level
$112.55
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding ZBH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($116.24)
- BULLISH: Expecting earnings turnaround to 5.1% growth with 3.1% revenue growth
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
11.96
Wall Street Target
$116.24
(+8.3%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
-13.8%
Profit Margin
8.9%
Valuation Premium vs History
+5.1% premium
PE vs Historical
12.0 vs 10.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$112.79
(+5%)
2-Year Target
$118.55
(+11%)
3-Year Target
$124.59
(+16%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$107.34
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.0%)
$206.67
(+93%)
Base:
(SPY PE: 12.0, Growth: 5.0%)
$124.41
(+16%)
Bear:
(PE: 10.2, Growth: 5.0%)
$105.75
(-2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 27.36 | Current EPS (TTM): $3.96
Bull Case
$238.33
(+122%)
Analyst growth 100.0%, PE expands to 30.1
Base Case
$216.66
(+102%)
Market implied 100.0%, PE stable at 27.4
Bear Case
$73.66
(-31%)
Severe decline -20.0%, PE contracts to 23.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ZBH Analysis
Share this live ZBH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ZBH)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Zimmer Biomet's Q2 earnings report showed a 4.8% YoY revenue increase and raised the 2026 outlook, leading to a bullish reaction from traders and a stock price increase of over 5%.
Key Retail Themes:
Positive Q2 earnings report
Raised 2026 outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 11:52 PM ET
Data refreshes hourly during market hours. Next update: 12:52 AM
Data refreshes hourly during market hours. Next update: 12:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZBH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 43 HOLD |
Advanced ZBH Option Strategies
Professional options setups generated by AI based on today's ZBH price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZBH Research Pages
